Slides on Lessons Learned From Lockdown: Viral Hepatitis–Related Liver Disease in the COVID-19 Era

Key slides on COVID-19 and viral hepatitis–related chronic liver disease (CLD), including COVID-19 outcomes in patients with CLD and expert guidance on clinical management, vaccination, and optimization of telemedicine for patients with CLD during the COVID-19 pandemic.
Format: Microsoft PowerPoint (.ppt)
File Size: 483 KB
Released: January 10, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grants provided by:
AbbVie
Gilead Sciences, Inc.

Related Content

Clinical Care Options (CCO) podcast with Dr Stefan Zeuzem on key viral hepatitis data from AASLD 2022

Stefan Zeuzem, MD Released: December 6, 2022

Dr Nancy Reau: practice-changing viral hepatitis data from AASLD 2022, from Clinical Care Options (CCO)

Nancy Reau, MD Released: December 6, 2022

Dr Stefan Zeuzem discusses his take on new viral hepatitis data from AASLD 2022, from Clinical Care Options (CCO)

Stefan Zeuzem, MD Released: December 5, 2022

Dr Nancy Reau discusses her take on new viral hepatitis data from AASLD 2022, from Clinical Care Options (CCO)

Nancy Reau, MD Released: December 2, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings